Page 136 - scheppingen

five
134
51. Kong W, He L, Richards EJ, et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. Oncogene. 2014 Feb 6;33(6):679-89.
52. Lopez-Ramirez MA, Wu D, Pryce G, et al. MicroRNA-155 negatively affects blood-brain barrier func- tion during neuroinflammation. FASEB J. 2014 Jun;28(6):2551-65.
53. Wu XY, Fan WD, Fang R, Wu GF. Regulation of microRNA-155 in Endothelial Inflammation by Targeting Nuclear Factor (NF)-kappaB P65. J Cell Biochem. 2014 Nov;115(11):1928-36.
54. Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. The European journal of neurosci- ence. 2010 Mar;31(6):1100-7.
55. Gorter JA, van Vliet EA, Aronica E, et al. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006 Oct 25;26(43):11083-110.
56. Omran A, Peng J, Zhang C, et al. Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia. 2012 Jul;53(7):1215-24.
57. Harter DH, Bassani L, Rodgers SD, et al. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatr. 2014 Jan;13(1):21-8.
58. Ouyang T, Zhang N, Benjamin T, et al. Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst. 2014 Apr;30(4):561-70.
59. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009 Jan;13(1):39-53.
60. Moore LM, Zhang W. Targeting miR-21 in glioma: a small RNA with big potential. Expert Opin Ther
Targets. 2010 Nov;14(11):1247-57.
61. Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease.
RNA biology. 2011 Sep-Oct;8(5):706-13.
62. Natsume A, Kinjo S, Yuki K, et al. Glioma-initiating cells and molecular pathology: implications for
therapy. Brain Tumor Pathol. 2011 Feb;28(1):1-12.
63. Moffett HF, Novina CD. A small RNA makes a Bic difference. Genome Biol. 2007;8(7):221.
64. Tili E, Michaille JJ, Croce CM. MicroRNAs play a central role in molecular dysfunctions linking
inflammation with cancer. Immunol Rev. 2013 May;253(1):167-84.
65. Elton TS, Selemon H, Elton SM, Parinandi NL. Regulation of the MIR155 host gene in physiological
and pathological processes. Gene. 2013 Dec 10;532(1):1-12.
66. Tarassishin L, Lee SC. Interferon regulatory factor 3 alters glioma inflammatory and invasive prop-
erties. J Neurooncol. 2013 Jun;113(2):185-94.
67. Mei J, Bachoo R, Zhang CL. MicroRNA-146a inhibits glioma development by targeting Notch1.
Molecular and cellular biology. 2011 Sep;31(17):3584-92.
68. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting
of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nature immunology.
2010 Feb;11(2):141-7.
69. O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annual
review of immunology. 2012;30:295-312.
70. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting
of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010
Feb;11(2):141-7.
71. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: a new form of intercellular com-
munication. Trends Cell Biol. 2012 Mar;22(3):125-32.
72. Zhang Q, Xu J, Chen Q, Chen X, Zen K, Zhang CY. Selective secretion of microRNA in CNS system.
Protein & cell. 2013 Apr;4(4):243-7.
73. Lehmann SM, Kruger C, Park B, et al. An unconventional role for miRNA: let-7 activates Toll-like
receptor 7 and causes neurodegeneration. Nature neuroscience. 2012 Jun;15(6):827-35.
74. Jin XF, Wu N, Wang L, Li J. Circulating microRNAs: a novel class of potential biomarkers for diag- nosing and prognosing central nervous system diseases. Cellular and molecular neurobiology.
2013 Jul;33(5):601-13.
75. Wang J, Tan L, Tan L, et al. Circulating microRNAs are promising novel biomarkers for drug-resis-
tant epilepsy. Scientific reports. 2015;5:10201.
76. Wang J, Yu JT, Tan L, et al. Genome-wide circulating microRNA expression profiling indicates bio-